ArticleInvestigational new drugs2012

A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study.

Warren P Mason et al.PubMed ↗Publisher ↗

No numbers read from the abstract.